Review of Mesna (Mistabron) as a Mucolytic for Preventing Plumonary complications in Intensive Care Setting.
Article
Dans En
| IMSEAR
| ID: sea-157619
ABSTRACT
Impaired mucus clearance or mucus hypersecretion are important feature of many pathological respiratory conditions and in ICU patients. Mesna is a potent mucolytic available as 200 mg/ml solution for neublization and endotracheopulmonary instillation. As effective “mucus clearance” is critical in managing post-operative and other ICU conditions to prevent complications like atelectasis and hypoxia, there is a need to review the clinical results of mucolytic agent Mesna, and its role in mucociliary clearance in critical care patients and in other respiratory conditions.
Texte intégral:
1
Indice:
IMSEAR
Sujet Principal:
Antitussifs
/
Complications postopératoires
/
Troubles respiratoires
/
Humains
/
Clairance mucociliaire
/
Mesna
/
Expectorants
/
Unités de soins intensifs
langue:
En
Année:
2014
Type:
Article